Fig. 2
From: An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues
The immunohistochemical approach to identify mutant β-catenin in colon adenoma TMAs. Immunohistochemical staining patterns of mutant (a–c) and wild-type (d–f) β-catenin (from left to right: H&E, total β-catenin, active β-catenin/ABC). CTNNB1 exon 3 deletion in RT-PCR (g) and point mutation in CTNNB1 S37 (h) are seen. Scale bars, 200 μm
